BioCentury | Jun 17, 2002
Finance

Ebb & Flow

...have some rights or maybe some rights of first refusal on Proskelia's products." Private rounds BASF Venture Capital...
...nanotech play Oxonica , which raised £4 million ($5.8 million) in its first institutional round. BASF Venture Capital...
Items per page:
1 - 1 of 1
BioCentury | Jun 17, 2002
Finance

Ebb & Flow

...have some rights or maybe some rights of first refusal on Proskelia's products." Private rounds BASF Venture Capital...
...nanotech play Oxonica , which raised £4 million ($5.8 million) in its first institutional round. BASF Venture Capital...
Items per page:
1 - 1 of 1